SUBSCRIBERS

Drugmakers court fight underscores high stakes in haemophilia

Published Mon, Jul 10, 2017 · 09:50 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Zurich

ROCHE'S bid to muscle in on Shire's share of the US$11 billion haemophilia drug market took a new, contentious turn this weekend when the British drugmaker won a court injunction against how the Swiss drugmaker talks about its new medicine.

Shire's injunction on Sunday in a Hamburg, Germany, court alleges incomplete and misleading statements by Roche about its investigational emicizumab.

Share with us your feedback on BT's products and services